Humana Inc. (HUM) CEO Bruce Broussard on Q2 2022 Results - Earnings Call Transcript

Humana Inc. (NYSE:HUM) Q2 2022 Earnings Conference Call July 27, 2022 9:00 AM ET

Company Participants

Lisa Stoner - Vice President, Investor Relations

Bruce Broussard - President and Chief Executive Officer

Susan Diamond - Chief Financial Officer

Joe Ventura - Chief Legal Officer

Conference Call Participants

Justin Lake - Wolfe Research

Matt Borsch - BMO Capital Markets

Kevin Fischbeck - Bank of America

A.J. Rice - Credit Suisse

Nathan Rich - Goldman Sachs

Joshua Raskin - Nephron Research

Ricky Goldwasser - Morgan Stanley

Stephen Baxter - Wells Fargo

Scott Fidel - Stephens

Steve Valiquette - Barclays

David Windley - Jefferies

George Hill - Deutsche Bank

Gary Taylor - Cowen

Rob Cottrell - Cleveland Research

Lisa Stoner

[Technical Difficulty]

…Humana’s President and Chief Executive Officer and Susan Diamond, Chief Financial Officer, will discuss our second quarter 2022 results and our updated financial outlook for 2022. Following these prepared remarks, we will open up the line for a question-and-answer session with industry analysts.

Joe Ventura, our Chief Legal Officer, will also be joining Bruce and Susan for the Q&A session. We encourage the investing public and media to listen to both management’s prepared remarks and the related Q&A with analysts. This call is being recorded for replay purposes. That replay will be available on the Investor Relations page of Humana’s website, humana.com, later today.

Before we begin our discussion, I need to advise call participants of our cautionary statement. Certain of the matters discussed in this conference call are forward-looking and involve a number of risks and uncertainties. Actual results could differ materially. Investors are advised to read the detailed risk factors discussed in our latest Form 10-K and other filings with the Securities and Exchange Commission and our second quarter 2022 earnings press release as they relate to forward-looking statements and to note in particular that these forward-looking statements could be impacted by risks related to the spread of in response to the COVID-19 pandemic.

Our forward-looking statements should therefore be considered in light of these additional uncertainties and risks, along with the other risks discussed in our SEC filings. We undertake no obligation to publicly address or update any forward-looking statements in future filings or communications regarding our business or results. Today’s press release, our historical financial news releases and our filings with the SEC are also available on our Investor Relations site.